VivoSim Labs, Inc.
NASDAQTotal Valuation
VivoSim Labs, Inc. carries a market capitalization of 714,592.00, placing it among publicly traded companies globally. Its enterprise value stands at -437,837.83, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 714,592.00 |
| Enterprise Value | -437,837.83 |
Share Statistics
VivoSim Labs, Inc. currently has 2.89M shares outstanding.
| Shares Outstanding | 2.89M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 28.08, and the price-to-book ratio stands at -3.77.
| PE Ratio | N/A |
| PS Ratio | 28.08 |
| PB Ratio | -3.77 |
| P/TBV Ratio | -3.77 |
| P/FCF Ratio | -0.34 |
| P/OCF Ratio | -0.34 |
Enterprise Valuation
| EV / Sales | 18.81 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
VivoSim Labs, Inc. maintains a current ratio of 2.38, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -40.67, indicating conservative leverage, while an interest coverage ratio of -939.33 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.38 |
| Quick Ratio | 2.18 |
| Debt / Equity | -40.67 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | -939.33 |
Financial Efficiency
| Return on Equity (ROE) | -112.51 |
| Return on Assets (ROA) | -125.64 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.02 |
Taxes
| Income Tax | 2,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
VivoSim Labs, Inc.'s stock has declined approximately -87.69027% over the past 52 weeks. The 50-day moving average sits at 0.52, while the 200-day moving average is 1.45.
| Beta (5Y) | N/A |
| 52-Week Price Change | -87.69027% |
| 50-Day Moving Average | 0.52 |
| 200-Day Moving Average | 1.45 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, VivoSim Labs, Inc. generated 131,000.00 in revenue and converted that into -13.84M in net income, yielding earnings per share of -5.38. EBITDA reached -11.27M, while operating income came in at -11.49M.
| Revenue | 131,000.00 |
| Gross Profit | 131,000.00 |
| Operating Income | -11.49M |
| Pretax Income | -13.84M |
| Net Income | -13.84M |
| EBITDA | -11.27M |
| EBIT | -11.49M |
| Earnings Per Share (EPS) | -5.38 |
Balance Sheet
VivoSim Labs, Inc. holds 5.02M in cash and equivalents against 447,000.00 in total debt, resulting in a net debt position of -5.02M. Total book value stands at -1.10M, with working capital of 3.84M providing operational flexibility.
| Cash & Cash Equivalents | 5.02M |
| Total Debt | 447,000.00 |
| Net Debt | -5.02M |
| Equity (Book Value) | -1.10M |
| Book Value Per Share | -0.38 |
| Working Capital | 3.84M |
Cash Flow
VivoSim Labs, Inc. produced -10.83M in operating cash flow over the past twelve months.
| Operating Cash Flow | -10.83M |
| Capital Expenditures | N/A |
| Free Cash Flow | -10.83M |
| FCF Per Share | -4.21 |
Margins
VivoSim Labs, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -8,768.70 and net profit margin of -10,567.18 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -8,768.70 |
| Pretax Margin | -10,565.65 |
| Profit Margin | -10,567.18 |
| EBITDA Margin | -8,604.58 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -107.39 |
| FCF Yield | -294.35 |
Scores
VivoSim Labs, Inc. posts an Altman Z-Score of -71.68, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -71.68 |